VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

GU Cancers 2019 | Impact of specific mutations on PARP inhibition in prostate cancer

Emmanuel Antonarakis, MBBCh, of Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA. He dicusses a recent publication by his group on the impact of certain genes mutations on PARP inhibition in prostate cancer, including ATM, CDK12 and BRCA1/2.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter